12:00 AM
 | 
Oct 19, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Symbicort budesonide/formoterol regulatory update

Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA from AstraZeneca for Symbicort Turbuhaler budesonide/formoterol for the maintenance treatment of asthma in patients ages 16...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >